Clinical Trials at University of Arizona
As of September 2026, 69 paid clinical trials are recruiting at University of Arizona, located at University of Arizona Health Sciences, 1501 N Campbell Ave, Tucson, AZ 85721, phone (520) 626-1197 in Tucson, Arizona. Active studies at this site cover conditions such as Obesity, Overweight and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
69 clinical trials at University of Arizona
·Clear filters·A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Child and Adolescent Registry for Participants With Narcolepsy
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
The Ailliance Post-Market Clinical Study
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
A Study of TAK-755 in Adults With Acute Ischemic Stroke
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Hypknowledge Nationwide Sleep Extension
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy
Endotype DIrected Treatment for OSA in Down Syndrome
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
RA-PRO PRAGMATIC TRIAL
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
The Effect of Semantic Support on Word Learning
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Lupus Landmark Study: A Prospective Registry and Biorepository
Platform of Randomized Adaptive Clinical Trials in Critical Illness
Common conditions studied in Tucson
- Obesity (13 active studies)
- Overweight (11 active studies)
- Breast Cancer (10 active studies)
- Acute Myeloid Leukemia (8 active studies)
- Cardiovascular Diseases (7 active studies)
- Hypertension (7 active studies)
Leading research sponsors in Tucson
- University of Arizona
- Eli Lilly and Company
- AstraZeneca
- National Cancer Institute (NCI)
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Tucson?
There are approximately 458 recruiting clinical trials in Tucson, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tucson pay participants?
Most recruiting trials in Tucson compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tucson?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tucson?
The most common conditions under active study in Tucson include Obesity (13), Overweight (11), Breast Cancer (10), Acute Myeloid Leukemia (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tucson?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tucson on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tucson?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tucson?
Recruiting research sites in Tucson include University of Arizona, Banner University Medical Center - Tucson, University of Arizona Cancer Center-North Campus, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tucson right now?
The largest active categories in Tucson are Cancer & tumors (154), Diabetes & metabolic (36), Cardiovascular (34). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Arizona?
University of Arizona is located at University of Arizona Health Sciences, 1501 N Campbell Ave, Tucson, AZ 85721. Use the Google Maps link in the intro above to get directions.
How do I contact University of Arizona?
You can reach University of Arizona by phone at (520) 626-1197. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.